^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Title:

Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia

Published date:
05/20/2021
Excerpt:
CD49d-negative CLL cases were more sensitive to lenalidomide treatment.
DOI:
10.1002/hon.2888